Pharmaceutical formulation comprising neurokinin antagonist

Details for Australian Patent Application No. 2007338359 (hide)

Owner Novartis AG

Inventors Mueller, Irene; Lakshman, Jay Parthiban; Timpe, Carsten; Schuetz, Helmut; Herbig, Michael; Kalb, Oskar; Ottinger, Isabel; Ries, Angelika; Diederich, Anke

Agent Davies Collison Cave

Pub. Number AU-B-2007338359

PCT Pub. Number WO2008/077591

Priority 06126964.3 22.12.06 EP

Filing date 20 December 2007

Wipo publication date 3 July 2008

Acceptance publication date 28 April 2011

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

Event Publications

11 June 2009 PCT application entered the National Phase

  PCT publication WO2008/077591 Priority application(s): WO2008/077591

28 April 2011 Application Accepted

  Published as AU-B-2007338359

25 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007338360-Method for purifying RNA on a preparative scale by means of HPLC

2007338357-Package for medicament